ClinicalTrials.Veeva

Menu

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy (LAM-SEPSIS)

A

Azienda Ospedaliera Città della Salute e della Scienza di Torino

Status

Unknown

Conditions

Acute Myeloid Leukemia

Study type

Observational

Funder types

Other

Identifiers

NCT05249894
LAM-SEPSIS

Details and patient eligibility

About

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of sepsis scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

Enrollment

400 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of non M3 Acute Myeloid Leukemia according to WHO (World Health Organization) 2008 criteria
  • Age >= 18 years and <= 70 years
  • Patient had received intensive chemotherapy either as induction or consolidation regimen
  • Period of observation: January 2001 - December 2019
  • Written informed consent

Exclusion criteria

  • Diagnosis of Acute Promyelocytic Leukemia (M3 AML)
  • Age < 18 or >70 years
  • Patient had not received intensive chemotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Chiara Frairia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems